Oesophageal carcinoma (Q34325751)

1 August 2017

1 reference

title

Oesophageal carcinoma. (English)

1 reference

1 August 2017

Arjun Pennathur

1

1 reference

1 August 2017

Michael K Gibson

series ordinal

2

1 reference

1 August 2017

Blair A Jobe

series ordinal

3

1 reference

1 August 2017

James D Luketich

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 February 2013

1 reference

1 August 2017

1 reference

1 August 2017

volume

381

1 reference

1 August 2017

issue

9864

1 reference

1 August 2017

page(s)

400-412

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

1 reference

7 January 2021

Continuing rapid increase in esophageal adenocarcinoma in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Resection for esophageal cancer: strategies for optimal management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Esophageal cancer: epidemiology, pathogenesis and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Epidemiology of esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Oesophageal cancer in The Netherlands: increasing incidence and mortality but improving survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Adenocarcinoma of the oesophagus: incidence and survival rates in New South Wales, 1972-2005.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Genetic polymorphisms of ADH2 and ALDH2 association with esophageal cancer risk in southwest China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Radiation Therapy for Breast Cancer and Increased Risk for Esophageal Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Prospective study of serum vitamin E levels and esophageal and gastric cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Prospective study of tooth loss and incident esophageal and gastric cancers in China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

The tylosis esophageal cancer (Toc) locus: more than just a familial cancer gene*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Black (air-cured) and blond (flue-cured) tobacco and cancer risk. III: Oesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Carcinogenetic impact of alcohol intake on squamous cell carcinoma risk of the oesophagus in relation to tobacco smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Population attributable risks of esophageal and gastric cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Helicobacter pylori and esophageal cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Prevalence of overweight and obesity in the United States, 1999-2004

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Obesity correlates with gastroesophageal reflux

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

1 reference

7 January 2021

Clinical practice. Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Prevalence of Barrett's esophagus in the general population: an endoscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Central adiposity and risk of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Surgical aspects of the patient with high-grade dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Hallmarks of cancer progression in Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Aneuploidy and Overexpression of Ki67 and p53 as Markers for Neoplastic Progression in Barrett's Esophagus: A Case–Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Carcinoma of the esophagus and esophagogastric junction: sensitivity of radiographic diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Biopsy-negative malignant esophageal stricture: diagnosis by endoscopic ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

CALGB 9380: a prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

A cancer staging primer: esophagus and esophagogastric junction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Endosonographic Staging of Esophageal Cancer: A Review of Literature Results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Endoscopic ultrasound compared with laparoscopy for staging esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: Results of the American College of Surgeons Oncology Group Z0060 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

The "best operation" for esophageal cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Transhiatal esophagectomy: clinical experience and refinements

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Ivor Lewis esophagogastrectomy for esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Hospital volume and surgical mortality in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Intensive care unit physician staffing is associated with decreased length of stay, hospital cost, and complications after esophageal resection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Oesophagectomy by a transhiatal approach or thoracotomy: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

A Prospective Randomized Trial of Extended Cervical and Superior Mediastinal Lymphadenectomy for Carcinoma of the Thoracic Esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Outcomes after minimally invasive esophagectomy: review of over 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the Esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Adjuvant chemotherapy for resected adenocarcinoma of the esophagus, gastro-esophageal junction, and cardia: phase II trial (E8296) of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: The Japan clinical oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Radiofrequency ablation in Barrett's esophagus with dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Treatment for Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Esophageal palliation--photodynamic therapy/stents/brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Results of expandable metal stents for malignant esophageal obstruction in 100 patients: short-term and long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

No effect of riboflavine, retinol, and zinc on prevalence of precancerous lesions of oesophagus. Randomised double-blind intervention study in high-risk population of China.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Cancer prevention with freeze-dried berries and berry components

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Chemoprevention of oesophageal cancer and the AspECT trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Improving surveillance for Barrett's oesophagus: AspECT and BOSS trials provide an evidence base

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960643-6

7 January 2021

10.1016/S0140-6736(12)60643-6

Identifiers

DOI

1 reference

1 August 2017

1 reference